Brio Capital Master Fund Ltd. 13D/13G Filings for Sigyn Therapeutics, Inc. (SIGY)

Brio Capital Master Fund Ltd. 13D and 13G filings for Sigyn Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-04
10:47 am
Purchase		 2022-01-27 13G Sigyn Therapeutics, Inc.
SIGY		 Brio Capital Master Fund Ltd. 93,146
9.990%		 7,766increase
(+9.10%)		 Filing
2021-01-27
12:35 pm
Purchase		 2021-01-17 13G Sigyn Therapeutics, Inc.
SIGY		 Brio Capital Master Fund Ltd. 85,380
9.990%		 85,380increase
(New Position)		 Filing